-+ 0.00%
-+ 0.00%
-+ 0.00%

Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus

Barchart·09/15/2026 08:53:00
Listen to the news

DALLAS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- (www.InvestorsTape.com) -- The Chief Executive Officer of NeOnc Technologies Holdings (NASDAQ:NTHI), Amir F. Heshmatpour has purchased another 37,000 shares of the company’s common stock, adding to his investment following NeOnc’s announcement of a $15 million financing with healthcare-focused institutional investors.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.